Turn.bio Company
Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. We are focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.
Headquarters:
Mountain View, California, United States
Funding Status:
Seed
Founded Date:
Feb 2019
Number Of Exists:
1-10
Last Funding Type:
Funding Round
Investors Number:
5
Last Funding Date:
Apr 28, 2021
Estimated Revenue:
Less than $1M
Employee Number:
1-10
Industry:
Biotechnology, Gene therapy, Genetics, Health Care, Therapeutics